Journal of Chromatography B · 2018 · 34 citations · 27 references
PharmacyPharmaceutical AnalysisPharmacologyChromatographic AnalysisClinical PharmacologyMass Spectrometric AnalysisBioanalytical Method ValidationCerebrospinal Fluid BiomarkersMass SpectrometryMass Spectrometry-based MetabolomicsMetabolite IdentificationMetabolite QuantificationCerebrospinal Fluid AnalysisLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisMass Spectrometric Drug AnalysisMetabolite Assay DevelopmentQuantitative Chromatography-mass SpectrometryUltra-performance Liquid Chromatography-mass Spectrometry
27
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Hematology, Oncology +17
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text
Medicine, Oncology, Pharmacotherapy +11
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li et al. · ChemMedChem · 2006 · 675 citations